A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

CMS Lifts Health Net Marketing and Enrollment Sanctions

Category: Medicare plan providers
Published: Aug, 01 2011 12:08:50


The Centers for Medicare & Medicaid Services (CMS) has released Health Net’s marketing and enrollment sanctions and Health Net, Inc. (Health Net) is once again approved to enroll new Members into their 2011 Medicare Part D prescription drug plans and Medicare Advantage plans with September 1, 2011 effective dates.  However, Low-Income Subsidy (LIS) recipients will not be automatically assigned or annual reassigned into the Health Net Medicare Part D prescription drug plans until at least March 1, 2012.  LIS recipients are still permitted to directly enroll themselves into a Health Net plan.  The following is the letter sent from CMS to Health Net on August 1st, 2011:

August 1, 2011

VIA:
FEDERAL EXPRESS DELIVERY (818)-676-6703
EMAIL (Jay.M.Gellert@healthnet.com)
FASCIMILE (818) 676-6616


Mr. Jay M. Gellert
President and Chief Executive Officer
Health Net, Inc.
21650 Oxnard Street
Woodland Hills, CA 91367
Phone (818) 676-6703


Re: Notice of Release of Intermediate Sanctions (Suspension of Marketing and Enrollment) For Medicare Advantage-Prescription Drug and Standalone Prescription Drug Plan Contracts: H0351, H0562, H5439, H5520, H6815 and S5678


Dear Mr. Gellert:

On November 19, 2010, the Centers for Medicare & Medicaid Services (CMS) imposed intermediate sanctions on Health Net, Inc. (Health Net), thereby suspending Health Net’s marketing and enrollment activities for all Health Net Medicare Advantage-Prescription Drug (MA-PD) and standalone Prescription Drug Program (PDP) contracts. CMS’ decision was based on Health Net’s serious deficiencies in the following operational areas: prescription drug (Part D) formulary and benefit administration, coverage determinations, redeterminations and appeals, and compliance program.

On May 5, 2011, CMS received your attestation stating that Health Net’s deficiencies were corrected and not likely to recur. On July 7, 2011 and July 8, 2011, CMS conducted extensive validation exercises at its Baltimore, Maryland headquarters to determine whether Health Net had corrected its deficiencies and whether they were not likely to recur. These exercises included a record and data review and remotely accessing Health Net’s prescription drug claim and coverage determination, appeals and grievances systems.

Based on these exercises, as well as additional information and assurances from Health Net, CMS has determined that Health Net has demonstrated sufficient progress in correcting its deficiencies to merit lifting the marketing and enrollment sanctions. Therefore, effective immediately, CMS is releasing the sanctions and Health Net may begin marketing to beneficiaries. Additionally, Health Net may begin enrolling beneficiaries with effective dates beginning September 1, 2011.

However, because CMS still considers Health Net to be a high-risk sponsor, CMS will continue to closely monitor and oversee Health Net’s operational activities. Health Net will be subject to targeted monitoring, heightened surveillance and oversight. Periodically, CMS will ask Health Net for specific data to provide CMS with an assurance that Health Net has fully addressed its deficiencies. CMS expects Health Net to work directly with its Regional Office Account Manager to provide any information requested by CMS and to ensure appropriate reporting to CMS of any new issues identified by Health Net.

Enrollment of Low-Income Subsidy Beneficiaries

Although Health Net is being released from the sanctions, CMS remains concerned about Health Net’s capacity to accept the potentially high volume of enrollments associated with CMS auto-enrollment and reassignment processes for low-income subsidy (LIS) enrollees. Notably, in January 2010, CMS determined that Health Net did not have the capacity to properly serve LIS beneficiaries because Health Net failed to adjudicate the appropriate LIS copayments at point of sale. As we stated in our January 7, 2010 letter to Scott Kelly regarding contract S5678, these failures resulted in our considering PDPs offered under that contract not to be “available” to receive autoenrollments. Since that time, Health Net has been unable to demonstrate a sufficient administration of the LIS benefit to prove the problems identified in our January 7, 2010 letter have been resolved. Further, Health Net reported in June 2011that it was not consistently reprocessing retrospective repayments and recoupments associated with members’ LIS status from 2008 to 2011. Health Net’s error affected approximately 125,000 LIS members.

Therefore, as a result of these concerns, CMS has determined that Health Net’s prescription drug plan (PDP) will continue to be excluded from the PDPs into which CMS carries out daily auto-enrollments or annual reassignment of LIS-eligible beneficiaries until at least March 1, 2012. This prohibition will remain in place until CMS is able to verify that Health Net has consistently demonstrated an ability to sufficiently administer its LIS benefit to its current enrollees. Thus, until further notice, Health Net will not receive any LIS-eligible individuals from CMS, and should not process enrollments for any LIS-eligible enrollees, unless those individuals affirmatively choose to enroll into a Health Net plan.

Although Health Net has assured CMS that its operational deficiencies (noted in the November 19, 2010 letter) have been corrected, CMS will monitor Health Net as it engages in marketing and enrollment for the 2011/2012 plan years before CMS concludes that it can entrust Medicare’s most vulnerable enrollees to Health Net. If Health Net continues to demonstrate to CMS that its deficiencies do not recur, CMS will reevaluate Health Net’s ability to administer the LIS benefit and may revise Health Net’s status at a later date. CMS’ evaluation may include, but is not limited to, Health Net’s ability to meet CMS LIS performance indicators and/or successfully perform during a CMS LIS Readiness Audit.

Corrective Action Required

During the sanction validation activities, CMS found several deficiencies, none of which prevent CMS from releasing Health Net from sanctions, but all of which merit corrective action. CMS will separately issue a notice of these deficiencies and provide an opportunity for your organization to demonstrate to CMS that these deficiencies are corrected. CMS expects Health Net to work directly with its Regional Office Account Manager to provide the information requested and to ensure ultimate correction of these identified deficiencies.

Please note that any further failures by Health Net to comply with these or any other CMS requirements may subject Health Net to other applicable remedies available under law, including the imposition of intermediate sanctions, civil money penalties and/or contract termination or non-renewal as described in 42 C.F.R. Parts 422 and 423, Subparts K and O.

If you have any questions about this notice, please call or email your designated point of contact within CMS.

Sincerely,

/s/

Brenda J. Tranchida
Director






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Compare Discounted Medication Prices
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.